Company Profile
AquaBounty Technologies Stock Price, News & Analysis
Company overview
Business overview
AquaBounty Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, AquaBounty Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
AquaBounty Technologies follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, AquaBounty Technologies sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
AQB is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
AquaBounty’s catalysts are operating updates, asset disposition, and any strategic step that clarifies the company’s future after its aquaculture reset. The stock is mainly about corporate resolution now.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
AquaBounty Technologies Announces First Quarter 2024 Financial Results
Source: AquaBounty Technologies
- 02
- 03
AquaBounty Technologies Announces Second Quarter 2024 Financial Results
Source: AquaBounty Technologies
- 04
AquaBounty Technologies Provides Update
Source: AquaBounty Technologies
- 05
AquaBounty Technologies Announces Third Quarter 2024 Financial Results
Source: AquaBounty Technologies
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.